Found: 7
Select item for more details and to access through your institution.
The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab‐containing line of therapy.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. E117, doi. 10.1002/ajh.26449
- By:
- Publication type:
- Article
Platelet characteristics in patients with essential thrombocytosis.
- Published in:
- Cytometry. Part B, 2018, v. 94, n. 6, p. 918, doi. 10.1002/cyto.b.21642
- By:
- Publication type:
- Article
The real-world outcomes of multiple myeloma patients treated with daratumumab.
- Published in:
- PLoS ONE, 2021, v. 16, n. 10, p. 1, doi. 10.1371/journal.pone.0258487
- By:
- Publication type:
- Article
Catheter‐directed thrombolysis for massive deep vein thrombosis in an adolescent with severe antithrombin deficiency.
- Published in:
- Clinical Case Reports, 2022, v. 10, n. 4, p. 1, doi. 10.1002/ccr3.5681
- By:
- Publication type:
- Article
Outcome of treatment with carfilzomib before and after treatment with daratumumab in relapsed or refractory multiple myeloma patients.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 521, doi. 10.1002/hon.2906
- By:
- Publication type:
- Article
The real‐world use and efficacy of pomalidomide for relapsed and refractory multiple myeloma in the era of CD38 antibodies.
- Published in:
- EJHaem, 2023, v. 4, n. 4, p. 1006, doi. 10.1002/jha2.774
- By:
- Publication type:
- Article
Prophylaxis with low dose tranexamic acid in acute myeloid leukemia patients undergoing intensive chemotherapy.
- Published in:
- EJHaem, 2023, v. 4, n. 3, p. 690, doi. 10.1002/jha2.699
- By:
- Publication type:
- Article